Experiment 1130263

Compounds isolated

Details

PropertyValue
Pharmacology
Administration routeIV
OrganismEmpty organism
CitationVOGL,SE: CAMACHO,FJ: KAPLAN,BH: O'DONNELL,MR:. (1984). PHASE II TRIAL OF VINDESINE IN ADVANCED SQUAMOUS CELL CANCER OF THE HEAD AND NECK.. 68(3)
Amount utilized
Compound isolated
DiseaseA PHASE II TRIAL GIVEN EVERY 7 DAYS FOR TREATMENT OF ADVANCED SQUAMOUS CELL CANCER OF THE HEAD. OF 25 PATIENTS THERE WERE 2 PARTIAL REMISSIONS. MEDIAN SURVIVAL WAS 3 MONTHS TOXIC EFFECTS INCLUDE PERIPHERIAL NEUROPATHY, AND ERYTHROPENIA.
Dose amount3.0 MG
Number1
Qualitative result.
AnimalHUMAN ADULT
Per unitSQ M BODY SURFACE
Dose expressionDOSE